APA aipamena

Conn, P. J., Yohn, S., Stansley, B., Foster, D., Plumley, H., & Lindsley, C. (2018). 43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA. Schizophr Bull.

Chicago Style aipamena

Conn, P Jeffrey, Samantha Yohn, Branden Stansley, Dan Foster, Hyekyung Plumley, and Craig Lindsley. "43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA." Schizophr Bull 2018.

MLA aipamena

Conn, P Jeffrey, et al. "43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA." Schizophr Bull 2018.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.